NF-KB Researchers

Bharat Aggarwal, MD Anderson Cancer Center

Kenneth Anderson, Dana Farber Cancer Institute

Marcello Arsura, University of Tennessee College of Mecine

Ariad Pharmaceuticals, Cambridge, MA, USA
Albert Baldwin, Jr., University of North Carolina at Chapel Hill
Dean Ballard, Vanderbilt University School of Medicine
David Baltimore, California Institute of Technology
Amer Beg, Columbia University
Yaron Ben-Neriah, Hebrew University-Hadassah Medical School (Israel)

 

Rudi Beyaert, University of Gent - VIB (Belgium)
Henry Bose, University of Texas at Austin
Vincent Bours, Universite de Liege (Belgium)

Jorge Caamano, University of Birmingham (England)
Tucker Collins, Harvard Medical School
Zhijian James Chen, University of Texas Southwestern
Riccardo Dalla-Favera, Columbia University

Joseph DiDonato, Lerner Research Institute (Cleveland Clinic)
Richard Gaynor, Eli Lilly Research Laboratories
Celine Gelinas, UMDNJ-Robert Wood Johnson Medical School
Steven Gerondakis, Walter & Eliza Hall Institute (Australia)
Gourisankar Ghosh, University of California at San Diego
Sankar Ghosh, Yale University School of Medicine
Warner Greene, University of California at San Francisco

Guy Haegeman, University of Gent (Belgium)

Mark Hannink, University of Missouri
Ronald Hay, University of St. Andrews (Scotland)
Norbert Herzog, University of Texas Medical Branch at Galveston

Alexander Hoffmann, University of California at San Diego

Jules Hoffmann, Inst. of Cellular and Molecular Biology (Strasbourg, France)

Dan Hultmark, Umea University (Sweden)
Jun-Ichiro Inoue,  University of Tokyo (Japan)
Y. Tony Ip, University of Massachusetts Medical School, Worcester
Alain Israel, Pasteur Institute (France)

Ruth Jarrett, University of Glasgow
Michael Karin, University of California at San Diego
Elliott Kieff, Harvard Medical School
Frank Lee, University of Pennsylvania School of Medicine
Chou-Chi Li, National Cancer Institute

Hsiou-Chi Liou, Cornell Medical School

Tak Mak, Princess Margaret Hospital (Toronto, Canada)
Tom Maniatis, Harvard University

Michael May, University of Pennsylania
Timothy McKeithan, University of Nebraska Medical Center
Frank Mercurio, Celgene Corporation (Signal Research Division)

Shigeki Miyamoto, University of Wisconsin-Madison

Jorge Moscat, CSIC-Universidad Autonoma (Spain)

George Mosialos, Alexander Fleming Research Institute (Greece)
Gary Nabel, Vaccine Research Center, National Institutes of Health

Harikrishna Nakshatri, Walther Oncology Center-Indiana School of Medicine

Gioacchino Natoli, Institute for Research in Biomedicine (Switzerland)

Gabriel Nunez, University of Michigan

Luke O'Neill, Trinity College (Ireland)
Lester Packer, University of California, Berkeley
Manolis Pasparakis, EMBL Monterotondo Mouse Biology Programme (Italy)
Neil Perkins, University of Dundee (Scotland)
Anjana Rao, Harvard Medical School
Thomas Rothstein, Boston University School of Medicine
Claus Scheidereit, Max-Delbruck Center for Molecular Medicine (Germany)
Robert Scheinman, University of Colorado
Ranjan Sen, National Institute on Aging
William Sha, University of California, Berkeley

Steven Shoelson, Joslin Diabetes Center of Harvard Medical School
Ulrich Siebenlist, National Institutes of Health
Gail Sonenshein, Boston University Medical School
George Stark, Lerner Research Institute (Cleveland Clinic)

Ruth Steward, UMDNJ- Robert Wood Johnson Institute
Louis Staudt, National Institutes of Health
Shao-Cong Sun, Penn State University College of Medicine

Dimitris Thanos, Alexander Fleming Research Institute (Greece)

Rune Toftgard, Karolinska Institute (Sweden)

Carter Van Waes, NIH
Inder Verma, Salk Institute

David Wallach, Weizmann Institute of Science (Israel)
Steven Wasserman, University of California at San Diego

Falk Weih, Institute of Toxicology and Genetics (Karlsruhe, Germany)
Ebrahim Zandi, University of Southern California